Cellectar Biosciences, Inc.
CLRBNASDAQ
Healthcare
Biotechnology
$2.68
+0.13(5.1%)
52W $2.50 – $13.85
Quick:
8-K
Mar 4, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 4, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 13, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 10, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 4, 2026 (2 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Nov 14, 2025 (4 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 13, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 13, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
S-1
Oct 20, 2025 (5 months ago)Registration Statement
IPO or secondary offering
Pricing, dilution, use of proceeds
8-K
Oct 10, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 6, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Aug 14, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 14, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Aug 8, 2025 (8 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Jul 8, 2025 (9 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
S-1/A
Jun 30, 2025 (9 months ago)Registration Statement (Amendment)
IPO or secondary offering
Pricing, dilution, use of proceeds
S-1
Jun 26, 2025 (9 months ago)Registration Statement
IPO or secondary offering
Pricing, dilution, use of proceeds